Profile | GDS4284 / 204077_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 597.267 | 67 |
GSM687648 | Patient 402 control | 538.273 | 65 |
GSM687653 | Patient 403 control | 528.084 | 65 |
GSM687658 | Patient 404 control | 396.528 | 60 |
GSM687663 | Patient 411 control | 561.298 | 65 |
GSM687668 | Patient 422 control | 569.895 | 66 |
GSM687673 | Patient 424 control | 846.586 | 71 |
GSM687678 | Patient 425 control | 850.027 | 71 |
GSM687683 | Patient 427 control | 545.983 | 64 |
GSM687688 | Patient 428 control | 1258.88 | 77 |
GSM687695 | Patient 441 control | 426.124 | 58 |
GSM687699 | Patient 443 control | 522.242 | 63 |
GSM687704 | Patient 444 control | 442.04 | 62 |
GSM687707 | Patient 448 control | 1452.29 | 80 |
GSM687712 | Patient 449 control | 481.378 | 63 |
GSM687719 | Patient 450 control | 1005.57 | 74 |
GSM687724 | Patient 451 control | 543.314 | 65 |
GSM687728 | Patient 452 control | 918.256 | 73 |
GSM687646 | Patient 401 treated 24h | 739.603 | 69 |
GSM687649 | Patient 402 treated 24h | 781.743 | 70 |
GSM687665 | Patient 411 treated 24h | 537.236 | 64 |
GSM687651 | Patient 402 treated 4 weeks | 870.057 | 72 |
GSM687667 | Patient 411 treated 4 weeks | 503.747 | 63 |
GSM687670 | Patient 422 treated 24h | 639.87 | 67 |
GSM687671 | Patient 422 treated 4 weeks | 658.304 | 67 |
GSM687654 | Patient 403 treated 24h | 513.326 | 65 |
GSM687675 | Patient 424 treated 24h | 841.397 | 71 |
GSM687685 | Patient 427 treated 24h | 479.099 | 63 |
GSM687656 | Patient 403 treated 4 weeks | 479.657 | 63 |
GSM687677 | Patient 424 treated 4 weeks | 1142.41 | 76 |
GSM687687 | Patient 427 treated 4 weeks | 581.832 | 66 |
GSM687692 | Patient 428 treated 4h | 940.779 | 73 |
GSM687716 | Patient 449 treated 4h | 534.827 | 65 |
GSM687722 | Patient 450 treated 4h | 881.764 | 72 |
GSM687680 | Patient 425 treated 24h | 777.553 | 70 |
GSM687690 | Patient 428 treated 24h | 1098.53 | 76 |
GSM687700 | Patient 443 treated 24h | 589.951 | 64 |
GSM687705 | Patient 444 treated 24h | 471.023 | 64 |
GSM687714 | Patient 449 treated 24h | 681.711 | 69 |
GSM687721 | Patient 450 treated 24h | 523.2 | 63 |
GSM687682 | Patient 425 treated 4 weeks | 958.896 | 73 |
GSM687694 | Patient 428 treated 4 weeks | 1085.95 | 75 |
GSM687702 | Patient 443 treated 4 weeks | 473.044 | 61 |
GSM687718 | Patient 449 treated 4 weeks | 730.069 | 70 |
GSM687723 | Patient 450 treated 4 weeks | 623.77 | 67 |
GSM687661 | Patient 404 treated 4h | 421.812 | 60 |
GSM687710 | Patient 448 treated 4h | 1269.88 | 78 |
GSM687726 | Patient 451 treated 4h | 862.968 | 72 |
GSM687730 | Patient 452 treated 4h | 696.294 | 65 |
GSM687660 | Patient 404 treated 24h | 695.801 | 70 |
GSM687697 | Patient 441 treated 24h | 681.975 | 68 |
GSM687709 | Patient 448 treated 24h | 1340.34 | 79 |
GSM687725 | Patient 451 treated 24h | 775.462 | 70 |
GSM687729 | Patient 452 treated 24h | 669.044 | 69 |
GSM687727 | Patient 451 treated 4 weeks | 890.889 | 72 |
GSM687731 | Patient 452 treated 4 weeks | 843.701 | 71 |